Precore and basal core promoter mutations in Asian American patients with hepatitis B e antigen-positive chronic hepatitis B

Alimentary Pharmacology and Therapeutics

Volumn 37, Issue 4, 2013, Pages 464-472

  Vutien, P ^a,b   Trinh, H N ^b,c   Nguyen, K ^b   Garcia, R T ^c   Nguyen, H A ^c   Levitt, B S ^c   Nguyen, L ^b,d   Ha, N B ^b,e   Ahmed, A ^e   Daugherty, T ^e   Garcia, G ^e   Nguyen, M H ^e  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Pacific Health Foundation   (United States)

^c San Jose Gastroenterology   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B(E) ANTIGEN; VIRUS DNA;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; ASIAN AMERICAN; BASAL CORE PROMOTER REGION; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DNA STRUCTURE; FEMALE; GENE MUTATION; GENOTYPE; HEPATITIS B; HUMAN; MAJOR CLINICAL STUDY; MALE; PRECORE REGION; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; UNITED STATES; VIRUS LOAD;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ASIAN AMERICANS; DNA, VIRAL; FEMALE; GENOTYPE; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MUTATION; PROMOTER REGIONS, GENETIC; RETROSPECTIVE STUDIES; UNITED STATES; VIRAL LOAD; YOUNG ADULT;

EID: 84872675181     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12193     Document Type: Article

References (35)

1. EASL Clinical Practice Guidelines: management of chronic hepatitis B. J Hepatol 2009; 50: 227-42.
2. Keeffe EB, Dieterich DT, Han SH, et al,. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 update. Clin Gastroenterol Hepatol 2008; 6: 1315-41.
3. Lok AS, McMahon BJ,. Chronic hepatitis B: update 2009. Hepatology 2009; 50: 661-2.
4. Chang TT, Gish RG, de Man R, et al,. A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B. N Engl J Med 2006; 354: 1001-10.
5. Dienstag JL, Cianciara J, Karayalcin S, et al,. Durability of serologic response after lamivudine treatment of chronic hepatitis B. Hepatology 2003; 37: 748-55.
6. Hsu YS, Chien RN, Yeh CT, et al,. Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B. Hepatology 2002; 35: 1522-7.
7. van Nunen AB, Hansen BE, Suh DJ, et al,. Durability of HBeAg seroconversion following antiviral therapy for chronic hepatitis B: relation to type of therapy and pretreatment serum hepatitis B virus DNA and alanine aminotransferase. Gut 2003; 52: 420-4.
8. Chaung KT, Ha NB, Trinh H, et al,. Recurrent HBV viremia following treatment induced hepatitis B e antigen seroconversion in chronic hepatitis B patients. J Clin Gastroenterol 2012; 46: 865-70.
9. Akahane Y, Yamanaka T, Suzuki H, et al,. Chronic active hepatitis with hepatitis B virus DNA and antibody against e antigen in the serum. Disturbed synthesis and secretion of e antigen from hepatocytes due to a point mutation in the precore region. Gastroenterology 1990; 99: 1113-9.
10. Brunetto MR, Giarin MM, Oliveri F, et al,. Wild-type and e antigen-minus hepatitis B viruses and course of chronic hepatitis. Proc Natl Acad Sci U S A 1991; 88: 4186-90.
11. Hamasaki K, Nakata K, Nagayama Y, et al,. Changes in the prevalence of HBeAg-negative mutant hepatitis B virus during the course of chronic hepatitis B. Hepatology 1994; 20: 8-14.
12. Chen CH, Lee CM, Hung CH, et al,. Clinical significance and evolution of core promoter and precore mutations in HBeAg-positive patients with HBV genotype B and C: a longitudinal study. Liver Int 2007; 27: 806-15.
13. Gunther S, Piwon N, Iwanska A, Schilling R, Meisel H, Will H,. Type, prevalence, and significance of core promoter/enhancer II mutations in hepatitis B viruses from immunosuppressed patients with severe liver disease. J Virol 1996; 70: 8318-31.
14. Gunther S, Piwon N, Will H,. Wild-type levels of pregenomic RNA and replication but reduced pre-C RNA and e-antigen synthesis of hepatitis B virus with C(1653) -> T, A(1762) -> T and G(1764) -> A mutations in the core promoter. J Gen Virol 1998; 79: 375-80.
15. Okamoto H, Tsuda F, Akahane Y, et al,. Hepatitis B virus with mutations in the core promoter for an e antigen-negative phenotype in carriers with antibody to e antigen. J Virol 1994; 68: 8102-10.
16. Qin Y, Zhang J, Mao R, et al,. Prevalence of basal core promoter and precore mutations in Chinese chronic hepatitis B patients and correlation with serum HBeAG titers. J Med Virol 2009; 81: 807-14.
17. Thompson AJ, Nguyen T, Iser D, et al,. Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers. Hepatology 2010; 51: 1933-44.
18. Chu CJ, Keeffe EB, Han SH, et al,. Prevalence of HBV precore/core promoter variants in the United States. Hepatology 2003; 38: 619-28.
19. Kim HJ, Yoo BC,. The prevalence and clinical significance of precore and core promoter mutations in Korean patients with chronic hepatitis B virus infection. Taehan Kan Hakhoe Chi 2002; 8: 149-56.
20. Tabernero D, Sanchez MJ, Homs M, et al,. Main mutations in the hepatitis B virus basic core promoter (A1762T/G1764A) before HBeAg loss are markers that identify patients who will require long-term treatment. Aliment Pharmacol Ther 2010; 32: 97-104.
21. Yuan HJ, Ka-Ho Wong D, Doutreloigne J, Sablon E, Lai CL, Yuen MF,. Precore and core promoter mutations at the time of HBeAg seroclearance in Chinese patients with chronic hepatitis B. J Infect 2007; 54: 497-503.
22. Ferns RB, Naoumov NV, Gilson RJ, Tedder RS,. Presence of hepatitis B virus core promoter mutations pre-seroconversion predict persistent viral replication after HBeAg loss. J Clin Virol 2007; 39: 199-204.
23. Datta S, Biswas A, Chandra PK, et al,. Molecular epidemiology and clinical significance of hepatitis B virus genotypes, core promoter and precore mutations in eastern India. Intervirology 2008; 51: 275-84.
24. Du H, Li T, Zhang HY, et al,. Correlation of hepatitis B virus (HBV) genotypes and mutations in basal core promoter/precore with clinical features of chronic HBV infection. Liver Int 2007; 27: 240-6.
25. Hagiwara S, Kudo M, Minami Y, et al,. Clinical significance of the genotype and core promoter/pre-core mutations in hepatitis B virus carriers. Intervirology 2006; 49: 200-6.
26. Jardi R, Rodriguez F, Buti M, et al,. Mutations in the basic core promoter region of hepatitis B virus. Relationship with precore variants and HBV genotypes in a Spanish population of HBV carriers. J Hepatol 2004; 40: 507-14.
27. Poustchi H, Mohamadkhani A, Bowden S, et al,. Clinical significance of precore and core promoter mutations in genotype D hepatitis B-related chronic liver disease. J Viral Hepat 2008; 15: 753-60.
28. Yuen MF, Tanaka Y, Ng IO, et al,. Hepatic necroinflammation and fibrosis in patients with genotypes Ba and C, core-promoter and precore mutations. J Viral Hepat 2005; 12: 513-8.
29. Hepatitis B Virus Drug Resistance, Genotype, and BCP/Precore Mutations. Available at: http://www.questdiagnostics.com/testcenter/TestDetail.action?ntc= 10529. Accessed August 15, 2012.
30. Nguyen LH, Ha NB, Vutien P, et al,. Prevalence of hepatitis B virus genotype B in Vietnamese patients with chronic hepatitis B. Hepatol Int 2009; 3: 461-7.
31. Chu CJ, Hussain M, Lok AS,. Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C. Gastroenterology 2002; 122: 1756-62.
32. Kramvis A, Arakawa K, Yu MC, Nogueira R, Stram DO, Kew MC,. Relationship of serological subtype, basic core promoter and precore mutations to genotypes/subgenotypes of hepatitis B virus. J Med Virol 2008; 80: 27-46.
33. Kramvis A, Kew MC,. Structure and function of the encapsidation signal of hepadnaviridae. J Viral Hepat 1998; 5: 357-67.
34. Lindh M, Andersson AS, Gusdal A,. Genotypes, nt 1858 variants, and geographic origin of hepatitis B virus-large-scale analysis using a new genotyping method. J Infect Dis 1997; 175: 1285-93.
35. Chotiyaputta W, Lok AS,. Hepatitis B virus variants. Nat Rev Gastroenterol Hepatol 2009; 6: 453-62.